Affiliation:
1. Department of Immunology, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Abstract
Recent epidemiologic studies indicate that leishmaniasis in the Americas is far more abundant and of greater public health importance than was previously recognized. The disease in the New World is caused by a number of different parasite species that are capable of producing a wide variety of clinical manifestations. The outcome of leishmanial infection in humans is largely dependent on the immune responsiveness of the host and the virulence of the infecting parasite strain. This article reviews current concepts of the clinical forms, immunology, pathology, laboratory diagnosis, and treatment of the disease as well as aspects of its epidemiology and control. Recommendations for future research on the disease and its control are made.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference328 articles.
1. Zoonotic cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis associated with domestic animals in Venezuela and Brazil;Aguilar C. M.;Mem. Inst. Oswaldo Cruz,1989
2. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica;Akuffo H.;Trans. R. Soc. Trop. Med. Hyg.,1990
3. Differential recognition of Leishmania aethiopica antigens by Iymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression;Akuffo H. O.;J. Immunol.,1988
4. /1975. Aspectos atuais do calazar no;Alencar J. E.;Ceara. Rev. Bras. Malariol. Doencas Trop.,1974
5. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature;Alters J.;AIDS,1991